# A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL

> **NCT02046694** · EARLY_PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 34 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia (ALL)

## Interventions

- **DRUG:** Allopurinol

## Key facts

- **NCT ID:** NCT02046694
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-06
- **Primary completion:** 2020-04-06
- **Final completion:** 2020-04-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046694, "A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02046694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*